# Open-label Prospective Clinical Trial Evaluating the Safety and Efficacy of Biosynthetic CLP-PEG-MPC Corneal Implants in Patients Undergoing High-risk Deep Anterior Lamellar Keratoplasty.

> **NCT05667337** · NA · WITHDRAWN · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)**

## Conditions studied

- High-risk Corneal Transplantation
- Corneal Blindess
- Corneal Inflammation
- Deep Anterior Lamellar Keratoplasty

## Interventions

- **DEVICE:** CLP-PEG-MPC
- **PROCEDURE:** Human donor cornea penetrating keratoplasty

## Key facts

- **NCT ID:** NCT05667337
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01-01
- **Primary completion:** 2040-01-01
- **Final completion:** 2040-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** further biomaterial optimization
- **Last updated:** 2022-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667337, "Open-label Prospective Clinical Trial Evaluating the Safety and Efficacy of Biosynthetic CLP-PEG-MPC Corneal Implants in Patients Undergoing High-risk Deep Anterior Lamellar Keratoplasty.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05667337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*